Purple Biotech (PPBT) EPS (Weighted Average and Diluted) (2022 - 2025)
Purple Biotech (PPBT) reported EPS (Weighted Average and Diluted) of $49.05 for Q4 2025, up 19516.95% year-over-year from N/an in Q4 2024, and up 19516.95% quarter-over-quarter from $0.25 in Q4 2024.
Purple Biotech (PPBT) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 4 years of EPS (Weighted Average and Diluted) data on file, last reported at $49.05 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at $49.05, up 19516.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $49.05 (up 19516.95% YoY), and the FY2025 annual result was $0.03, down 99.46% from the prior year.
- EPS (Weighted Average and Diluted) grew to $49.05 in Q4 2025 per PPBT's latest filing, from $0.25 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $49.05 in Q4 2025 and troughed at $0.25 in Q4 2024.
- A 4-year average of $15.08 and a median of $5.51 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) plunged 94.27% in 2024, then surged 19516.95% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at $6.65 in 2022, then sank by 34.39% to $4.36 in 2023, then sank by 94.27% to $0.25 in 2024, then surged by 19516.95% to $49.05 in 2025.
- Business Quant data shows PPBT's EPS (Weighted Average and Diluted) at $49.05 in Q4 2025, $0.25 in Q4 2024, and $4.36 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.05 |
| Dec 31, 2024 | 0.25 |
| Dec 31, 2023 | 4.36 |
| Dec 31, 2022 | 6.65 |